{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 7,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 3
      },
      "3": {
        "core": 1,
        "branch": 0
      },
      "4": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A13 → ¬A12)",
        "prover9_expression": "(approves_application(RegulatoryBody, Organization) -> -denies_application(RegulatoryBody, Organization))",
        "natural": "Provided that a regulatory body approves an organization's application, it is not the case that the regulatory body denies the organization's application."
      },
      {
        "id": "Rule2",
        "formal": "(A14 ∨ A15)",
        "prover9_expression": "(uses_vehicle(Organization, Vehicle) | alternative_transport(Organization))",
        "natural": "Either an organization uses a vehicle or the organization employs alternative transportation."
      },
      {
        "id": "Rule3",
        "formal": "(A15 → G)",
        "prover9_expression": "(alternative_transport(Organization) -> market_approval(Treatment))",
        "natural": "Should an organization adopt alternative transportation, then the treatment is approved for the market."
      },
      {
        "id": "Rule4",
        "formal": "(A17 → A18)",
        "prover9_expression": "(violates_protocol(Organization) -> faces_penalties(Organization))",
        "natural": "In the event that an organization violates a protocol, the organization faces penalties."
      },
      {
        "id": "Rule5",
        "formal": "(A17 ∨ (¬(A14 → G) → A16))",
        "prover9_expression": "(violates_protocol(Organization) | (-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> delays_study(Organization)))",
        "natural": "An organization violates a protocol or, if it is not the case that using a vehicle implies market approval for the treatment, then the organization delays the study."
      },
      {
        "id": "Rule6",
        "formal": "(A20 → A19)",
        "prover9_expression": "(hires_consultant(Organization) -> appeals_decision(Organization))",
        "natural": "Whenever an organization hires a consultant, the organization appeals a decision."
      },
      {
        "id": "Rule7",
        "formal": "(A21 → (A17 → ¬A18))",
        "prover9_expression": "(internal_review(Organization) -> (violates_protocol(Organization) -> -faces_penalties(Organization)))",
        "natural": "If an organization performs an internal review, then should the organization violate a protocol, it will not face penalties."
      },
      {
        "id": "Rule8",
        "formal": "(A22 ∨ (A20 ∨ A21))",
        "prover9_expression": "(public_disclosure(Organization) | (hires_consultant(Organization) | internal_review(Organization)))",
        "natural": "Either an organization makes a public disclosure, or the organization hires a consultant, or the organization conducts an internal review."
      },
      {
        "id": "Rule9",
        "formal": "(A23 → G)",
        "prover9_expression": "(receives_clearance(Organization, Treatment) -> market_approval(Treatment))",
        "natural": "Provided that an organization receives clearance for a treatment, the treatment receives market approval."
      },
      {
        "id": "Rule10",
        "formal": "(A24 → A23)",
        "prover9_expression": "(phase1_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
        "natural": "Should an organization achieve phase 1 success for a treatment, then the organization receives clearance for that treatment."
      },
      {
        "id": "Rule11",
        "formal": "(A25 → A23)",
        "prover9_expression": "(phase2_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
        "natural": "In the event that an organization achieves phase 2 success for a treatment, the organization receives clearance for the treatment."
      },
      {
        "id": "Rule12",
        "formal": "(A29 → (A8 → G))",
        "prover9_expression": "(publication_accepted(Study) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If a study is accepted for publication, then under the condition that the organization completes an animal study, the treatment receives market approval."
      },
      {
        "id": "Rule13",
        "formal": "(A30 → (A28 → A29))",
        "prover9_expression": "(journal_submission(Organization, Study) -> (peer_review(Organization, Study) -> publication_accepted(Study)))",
        "natural": "Should an organization submit a study to a journal, then if the study undergoes peer review, the study is accepted for publication."
      },
      {
        "id": "Rule14",
        "formal": "(A31 → A30)",
        "prover9_expression": "(data_analysis(Organization, Study) -> journal_submission(Organization, Study))",
        "natural": "In the event that an organization performs data analysis on a study, the organization submits the study to a journal."
      },
      {
        "id": "Rule15",
        "formal": "(A32 → (A8 → G))",
        "prover9_expression": "(international_collaboration(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If an organization engages in international collaboration, then provided that the organization completes an animal study, the treatment receives market approval."
      },
      {
        "id": "Rule16",
        "formal": "(A32 ∨ A33)",
        "prover9_expression": "(international_collaboration(Organization) | domestic_partnership(Organization))",
        "natural": "An organization pursues international collaboration or the organization enters a domestic partnership."
      },
      {
        "id": "Rule17",
        "formal": "(A34 → (A33 → (A8 → G)))",
        "prover9_expression": "(partnership_agreement(Organization, Partner) -> (domestic_partnership(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))))",
        "natural": "Under the condition that an organization enters a partnership agreement with a partner, then if the organization has a domestic partnership, then if the organization completes an animal study, the treatment receives market approval."
      },
      {
        "id": "Rule18",
        "formal": "(A37 → (A36 → A35))",
        "prover9_expression": "(attends_meeting(Organization, RegulatoryBody) -> (scheduled_meeting(Organization, RegulatoryBody) -> regulatory_meeting(Organization, RegulatoryBody)))",
        "natural": "Provided that an organization attends a meeting with a regulatory body, then if the organization schedules a meeting, a regulatory meeting happens."
      },
      {
        "id": "Rule19",
        "formal": "(A6 → ¬A5)",
        "prover9_expression": "(fails_funding(Organization, Disease) -> -receives_funding(Organization, Disease))",
        "natural": "Should an organization fail to obtain funding for a disease, then it is not the case that the organization receives funding for the disease."
      },
      {
        "id": "Rule20",
        "formal": "(A9 → A10)",
        "prover9_expression": "(submits_data(Organization, RegulatoryBody) -> passes_review(RegulatoryBody, Organization))",
        "natural": "Whenever an organization submits data to a regulatory body, the regulatory body passes the organization's review."
      },
      {
        "id": "Rule21",
        "formal": "(¬(A14 → G) → ¬A16)",
        "prover9_expression": "(-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> -delays_study(Organization))",
        "natural": "If it is not true that using a vehicle implies market approval for the treatment, then the organization does not delay the study."
      },
      {
        "id": "Rule22",
        "formal": "(¬(A2 → A3) → A4)",
        "prover9_expression": "(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> applies_authorization(Organization, Authorization))",
        "natural": "In the event that it is not the case that conducting research on a disease leads to developing a treatment, then the organization applies for authorization."
      },
      {
        "id": "Rule23",
        "formal": "(¬(A26 → (A24 ∨ A25)) → A27)",
        "prover9_expression": "(-(initiates_trial(Organization, Treatment) -> (phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment))) -> abandons_trial(Organization, Treatment))",
        "natural": "If it is not the case that initiating a trial results in phase 1 or phase 2 success, then the organization abandons the trial for the treatment."
      },
      {
        "id": "Rule24",
        "formal": "(¬(A9 → (A8 → G)) → A36)",
        "prover9_expression": "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> scheduled_meeting(Organization, RegulatoryBody))",
        "natural": "If it is not the case that submitting data results in an animal study completion implying market approval, then the organization schedules a meeting with the regulatory body."
      },
      {
        "id": "Rule25",
        "formal": "(¬(A9 → (A8 → G)) → ¬A35)",
        "prover9_expression": "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> -regulatory_meeting(Organization, RegulatoryBody))",
        "natural": "In the event that it is not true that submitting data implies that an animal study completion leads to market approval, then a regulatory meeting does not take place."
      },
      {
        "id": "Rule26",
        "formal": "(¬(¬(A10 → (A8 → G)) → A11) → A12)",
        "prover9_expression": "(-(-(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> requests_additional_data(RegulatoryBody, Organization)) -> denies_application(RegulatoryBody, Organization))",
        "natural": "If it is not the case that the negation of passing review implying animal study completion leads to market approval results in a request for additional data, then the regulatory body denies the organization's application."
      },
      {
        "id": "Rule27",
        "formal": "(¬(¬(A2 → A3) → ¬A4) → A5)",
        "prover9_expression": "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> receives_funding(Organization, Disease))",
        "natural": "Under the condition that it is not true that not conducting research leading to treatment development implies not applying for authorization, then the organization receives funding for the disease."
      },
      {
        "id": "Rule28",
        "formal": "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → A7)",
        "prover9_expression": "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> restructures(Organization))",
        "natural": "In the event that it is not the case that not not conducting research implying treatment development leading to not applying for authorization results in failing funding, then the organization restructures."
      },
      {
        "id": "Rule29",
        "formal": "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → ¬A7)",
        "prover9_expression": "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> -restructures(Organization))",
        "natural": "Provided that it is not true that not not conducting research resulting in treatment development implying not applying for authorization leads to failing funding, then the organization does not restructure."
      },
      {
        "id": "Rule30",
        "formal": "(¬(¬G → A1) → A2)",
        "prover9_expression": "(-(-market_approval(Treatment) -> has_approval(Organization, Authorization)) -> conducts_research(Organization, Disease))",
        "natural": "Should it not be the case that not market approval implies having authorization, then the organization conducts research on the disease."
      },
      {
        "id": "Rule31",
        "formal": "(¬A37 → A38)",
        "prover9_expression": "(-attends_meeting(Organization, RegulatoryBody) -> misses_meeting(Organization, RegulatoryBody))",
        "natural": "If an organization does not attend a meeting with a regulatory body, then the organization misses the meeting."
      },
      {
        "id": "Rule32",
        "formal": "(¬G → ¬A1)",
        "prover9_expression": "(-market_approval(Treatment) -> -has_approval(Organization, Authorization))",
        "natural": "Provided that a treatment does not obtain market approval, it is not the case that the organization has authorization."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A13",
        "prover9_expression": "approves_application(RegulatoryBody, Organization)",
        "natural": "A regulatory body approves an organization's application."
      },
      {
        "id": "Fact2",
        "formal": "A26",
        "prover9_expression": "initiates_trial(Organization, Treatment)",
        "natural": "An organization initiates a clinical trial for a treatment."
      },
      {
        "id": "Fact3",
        "formal": "A28",
        "prover9_expression": "peer_review(Organization, Study)",
        "natural": "An organization's study undergoes peer review."
      },
      {
        "id": "Fact4",
        "formal": "A31",
        "prover9_expression": "data_analysis(Organization, Study)",
        "natural": "An organization performs data analysis on a study."
      },
      {
        "id": "Fact5",
        "formal": "A34",
        "prover9_expression": "partnership_agreement(Organization, Partner)",
        "natural": "An organization enters a partnership agreement with a partner."
      },
      {
        "id": "Fact6",
        "formal": "A8",
        "prover9_expression": "completes_study(Organization, Animal)",
        "natural": "An organization completes a study involving animal subjects."
      },
      {
        "id": "Fact7",
        "formal": "A9",
        "prover9_expression": "submits_data(Organization, RegulatoryBody)",
        "natural": "An organization submits data to a regulatory body."
      },
      {
        "id": "Fact8",
        "formal": "¬A11",
        "prover9_expression": "-requests_additional_data(RegulatoryBody, Organization)",
        "natural": "It is not the case that a regulatory body requests additional data from an organization."
      },
      {
        "id": "Fact9",
        "formal": "¬A19",
        "prover9_expression": "-appeals_decision(Organization)",
        "natural": "An organization does not appeal a decision."
      },
      {
        "id": "Fact10",
        "formal": "¬A22",
        "prover9_expression": "-public_disclosure(Organization)",
        "natural": "An organization does not make a public disclosure."
      },
      {
        "id": "Fact11",
        "formal": "¬A27",
        "prover9_expression": "-abandons_trial(Organization, Treatment)",
        "natural": "An organization does not abandon a clinical trial for a treatment."
      },
      {
        "id": "Fact12",
        "formal": "¬A3",
        "prover9_expression": "-develops_treatment(Organization, Disease)",
        "natural": "An organization does not develop a treatment for a disease."
      },
      {
        "id": "Fact13",
        "formal": "¬A38",
        "prover9_expression": "-misses_meeting(Organization, RegulatoryBody)",
        "natural": "An organization does not miss a meeting with a regulatory body."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "market_approval(Treatment)",
    "natural": "A treatment receives market approval."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-(A2 -> A3) -> -A4) -> A6) -> A7)",
            "(-(-(-(A2 -> A3) -> -A4) -> A6) -> -A7)"
          ],
          "conclusion": "(-(-(A2 -> A3) -> -A4) -> A6)",
          "natural": "Should it not be the case that not conducting research implying treatment development leads to not applying for authorization, then the organization fails to obtain funding for the disease."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A2 -> A3) -> -A4) -> A6)",
            "(A6 -> -A5)"
          ],
          "conclusion": "(-(-(A2 -> A3) -> -A4) -> -A5)",
          "natural": "If it is not true that not conducting research resulting in treatment development implies not applying for authorization, then it is not the case that the organization receives funding for the disease."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A2 -> A3) -> -A4) -> A5)",
            "(-(-(A2 -> A3) -> -A4) -> -A5)"
          ],
          "conclusion": "(-(A2 -> A3) -> -A4)",
          "natural": "Provided that it is not true that conducting research implies developing a treatment, then the organization does not apply for authorization."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A2 -> A3) -> A4)",
            "(-(A2 -> A3) -> -A4)"
          ],
          "conclusion": "(A2 -> A3)",
          "natural": "Under the condition that an organization conducts research on a disease, the organization develops a treatment for that disease."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(A2 -> A3)",
            "-A3"
          ],
          "conclusion": "-A2",
          "natural": "An organization does not conduct research on a disease."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-G -> A1) -> A2)",
            "-A2"
          ],
          "conclusion": "(-G -> A1)",
          "natural": "In the event that a treatment does not receive market approval, the organization possesses authorization."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A13 -> -A12)",
            "A13"
          ],
          "conclusion": "-A12",
          "natural": "A regulatory body does not deny an organization's application."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A10 -> (A8 -> G)) -> A11) -> A12)",
            "-A12"
          ],
          "conclusion": "(-(A10 -> (A8 -> G)) -> A11)",
          "natural": "If it is not the case that passing review implies that completing an animal study leads to market approval, then the regulatory body requests additional data from the organization."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A10 -> (A8 -> G)) -> A11)",
            "-A11"
          ],
          "conclusion": "(A10 -> (A8 -> G))",
          "natural": "If a regulatory body passes an organization's review, then it follows that if the organization completes an animal study, then the treatment receives market approval."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A9 -> A10)",
            "(A10 -> (A8 -> G))"
          ],
          "conclusion": "(A9 -> (A8 -> G))",
          "natural": "If an organization submits data to a regulatory body, then under the condition that the organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A9 -> (A8 -> G))",
            "A9"
          ],
          "conclusion": "(A8 -> G)",
          "natural": "In the event that an organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A8 -> G)",
            "A8"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A22 | (A20 | A21))",
            "-A22"
          ],
          "conclusion": "(A20 | A21)",
          "natural": "An organization hires a consultant or the organization conducts an internal review."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A20 -> A19)",
            "(A21 -> (A17 -> -A18))",
            "(A20 | A21)"
          ],
          "conclusion": "(A19 | (A17 -> -A18))",
          "natural": "Either an organization appeals a decision, or if it violates a protocol, then it does not face penalties."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 -> -A18))",
            "-A19"
          ],
          "conclusion": "(A17 -> -A18)",
          "natural": "If an organization violates a protocol, then the organization does not face penalties."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A17 -> A18)",
            "(A17 -> -A18)"
          ],
          "conclusion": "-A17",
          "natural": "An organization does not violate a protocol."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A17 | (-(A14 -> G) -> A16))",
            "-A17"
          ],
          "conclusion": "(-(A14 -> G) -> A16)",
          "natural": "Should it not be the case that using a vehicle results in market approval for the treatment, then the organization delays the study."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A14 -> G) -> A16)",
            "(-(A14 -> G) -> -A16)"
          ],
          "conclusion": "(A14 -> G)",
          "natural": "Whenever an organization uses a vehicle, the treatment obtains market approval."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A14 | A15)",
            "(A14 -> G)",
            "(A15 -> G)"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A26 -> (A24 | A25)) -> A27)",
            "-A27"
          ],
          "conclusion": "(A26 -> (A24 | A25))",
          "natural": "If an organization initiates a trial for a treatment, then either the organization achieves phase 1 success or phase 2 success for the treatment."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (A24 | A25))",
            "A26"
          ],
          "conclusion": "(A24 | A25)",
          "natural": "An organization attains phase 1 success for a treatment or the organization achieves phase 2 success for the treatment."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> A23)",
            "(A25 -> A23)"
          ],
          "conclusion": "A23",
          "natural": "An organization receives clearance for a treatment."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A23 -> G)",
            "A23"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A31 -> A30)",
            "A31"
          ],
          "conclusion": "A30",
          "natural": "An organization submits a study to a journal."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A30 -> (A28 -> A29))",
            "A30"
          ],
          "conclusion": "(A28 -> A29)",
          "natural": "Provided that an organization's study is peer-reviewed, the study is accepted for publication."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A28 -> A29)",
            "(A29 -> (A8 -> G))"
          ],
          "conclusion": "(A28 -> (A8 -> G))",
          "natural": "Whenever an organization's study undergoes peer review, then if the organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A28 -> (A8 -> G))",
            "A28"
          ],
          "conclusion": "(A8 -> G)",
          "natural": "In the event that an organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A8 -> G)",
            "A8"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A34 -> (A33 -> (A8 -> G)))",
            "A34"
          ],
          "conclusion": "(A33 -> (A8 -> G))",
          "natural": "Whenever an organization participates in a domestic partnership, then if the organization completes an animal study, the treatment obtains market approval."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A32 | A33)",
            "(A32 -> (A8 -> G))",
            "(A33 -> (A8 -> G))"
          ],
          "conclusion": "(A8 -> G)",
          "natural": "In the event that an organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A8 -> G)",
            "A8"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-A37 -> A38)",
            "-A38"
          ],
          "conclusion": "A37",
          "natural": "An organization attends a meeting with a regulatory body."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A37 -> (A36 -> A35))",
            "A37"
          ],
          "conclusion": "(A36 -> A35)",
          "natural": "If an organization schedules a meeting with a regulatory body, then a regulatory meeting between the organization and the regulatory body occurs."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> (A8 -> G)) -> A36)",
            "(A36 -> A35)"
          ],
          "conclusion": "(-(A9 -> (A8 -> G)) -> A35)",
          "natural": "Should it not be true that submitting data leads to completing an animal study implying market approval, then a regulatory meeting occurs between the organization and the regulatory body."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A9 -> (A8 -> G)) -> A35)",
            "(-(A9 -> (A8 -> G)) -> -A35)"
          ],
          "conclusion": "(A9 -> (A8 -> G))",
          "natural": "If an organization submits data to a regulatory body, then under the condition that the organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A9 -> (A8 -> G))",
            "A9"
          ],
          "conclusion": "(A8 -> G)",
          "natural": "In the event that an organization completes an animal study, the treatment receives market approval."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A8 -> G)",
            "A8"
          ],
          "conclusion": "G",
          "natural": "A treatment receives market approval."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Research and Regulatory Approval",
    "atomic_facts": {
      "A1": "has_approval(Organization, Authorization)",
      "A2": "conducts_research(Organization, Disease)",
      "A3": "develops_treatment(Organization, Disease)",
      "A4": "applies_authorization(Organization, Authorization)",
      "A5": "receives_funding(Organization, Disease)",
      "A6": "fails_funding(Organization, Disease)",
      "A7": "restructures(Organization)",
      "A8": "completes_study(Organization, Animal)",
      "A9": "submits_data(Organization, RegulatoryBody)",
      "A10": "passes_review(RegulatoryBody, Organization)",
      "A11": "requests_additional_data(RegulatoryBody, Organization)",
      "A12": "denies_application(RegulatoryBody, Organization)",
      "A13": "approves_application(RegulatoryBody, Organization)",
      "A14": "uses_vehicle(Organization, Vehicle)",
      "A15": "alternative_transport(Organization)",
      "A16": "delays_study(Organization)",
      "A17": "violates_protocol(Organization)",
      "A18": "faces_penalties(Organization)",
      "A19": "appeals_decision(Organization)",
      "A20": "hires_consultant(Organization)",
      "A21": "internal_review(Organization)",
      "A22": "public_disclosure(Organization)",
      "A23": "receives_clearance(Organization, Treatment)",
      "A24": "phase1_success(Organization, Treatment)",
      "A25": "phase2_success(Organization, Treatment)",
      "A26": "initiates_trial(Organization, Treatment)",
      "A27": "abandons_trial(Organization, Treatment)",
      "A28": "peer_review(Organization, Study)",
      "A29": "publication_accepted(Study)",
      "A30": "journal_submission(Organization, Study)",
      "A31": "data_analysis(Organization, Study)",
      "A32": "international_collaboration(Organization)",
      "A33": "domestic_partnership(Organization)",
      "A34": "partnership_agreement(Organization, Partner)",
      "A35": "regulatory_meeting(Organization, RegulatoryBody)",
      "A36": "scheduled_meeting(Organization, RegulatoryBody)",
      "A37": "attends_meeting(Organization, RegulatoryBody)",
      "A38": "misses_meeting(Organization, RegulatoryBody)",
      "G": "market_approval(Treatment)"
    },
    "natural_facts": {
      "A1": "An organization possesses authorization from a regulatory body.",
      "A2": "An organization carries out research on a specific disease.",
      "A3": "An organization develops a treatment for a particular disease.",
      "A4": "An organization applies for an authorization.",
      "A5": "An organization secures funding for research on a disease.",
      "A6": "An organization fails to obtain funding for a disease.",
      "A7": "An organization undergoes restructuring.",
      "A8": "An organization completes a study involving animal subjects.",
      "A9": "An organization submits data to a regulatory body.",
      "A10": "A regulatory body passes an organization's review.",
      "A11": "A regulatory body requests additional data from an organization.",
      "A12": "A regulatory body denies an application from an organization.",
      "A13": "A regulatory body approves an application from an organization.",
      "A14": "An organization utilizes a vehicle.",
      "A15": "An organization employs alternative transportation.",
      "A16": "An organization delays a study.",
      "A17": "An organization violates a protocol.",
      "A18": "An organization faces penalties.",
      "A19": "An organization appeals a decision.",
      "A20": "An organization hires a consultant.",
      "A21": "An organization conducts an internal review.",
      "A22": "An organization makes a public disclosure.",
      "A23": "An organization receives clearance for a treatment.",
      "A24": "An organization achieves success in phase 1 trials for a treatment.",
      "A25": "An organization achieves success in phase 2 trials for a treatment.",
      "A26": "An organization initiates a clinical trial for a treatment.",
      "A27": "An organization abandons a clinical trial for a treatment.",
      "A28": "An organization's study undergoes peer review.",
      "A29": "A study is accepted for publication.",
      "A30": "An organization submits a study to a journal.",
      "A31": "An organization performs data analysis on a study.",
      "A32": "An organization engages in international collaboration.",
      "A33": "An organization participates in a domestic partnership.",
      "A34": "An organization enters a partnership agreement with a partner.",
      "A35": "An organization holds a regulatory meeting with a regulatory body.",
      "A36": "An organization schedules a meeting with a regulatory body.",
      "A37": "An organization attends a meeting with a regulatory body.",
      "A38": "An organization misses a meeting with a regulatory body.",
      "G": "A treatment receives market approval."
    },
    "prover9_expressions": [
      "(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(approves_application(RegulatoryBody, Organization) -> -denies_application(RegulatoryBody, Organization))",
      "(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment))",
      "(uses_vehicle(Organization, Vehicle) | alternative_transport(Organization))",
      "(alternative_transport(Organization) -> market_approval(Treatment))",
      "(violates_protocol(Organization) -> faces_penalties(Organization))",
      "(violates_protocol(Organization) -> -faces_penalties(Organization))",
      "(violates_protocol(Organization) | (-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> delays_study(Organization)))",
      "(appeals_decision(Organization) | (violates_protocol(Organization) -> -faces_penalties(Organization)))",
      "(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease))",
      "(hires_consultant(Organization) -> appeals_decision(Organization))",
      "(hires_consultant(Organization) | internal_review(Organization))",
      "(internal_review(Organization) -> (violates_protocol(Organization) -> -faces_penalties(Organization)))",
      "(public_disclosure(Organization) | (hires_consultant(Organization) | internal_review(Organization)))",
      "(receives_clearance(Organization, Treatment) -> market_approval(Treatment))",
      "(phase1_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
      "(phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment))",
      "(phase2_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
      "(initiates_trial(Organization, Treatment) -> (phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment)))",
      "(peer_review(Organization, Study) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(peer_review(Organization, Study) -> publication_accepted(Study))",
      "(publication_accepted(Study) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(journal_submission(Organization, Study) -> (peer_review(Organization, Study) -> publication_accepted(Study)))",
      "(data_analysis(Organization, Study) -> journal_submission(Organization, Study))",
      "(international_collaboration(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(international_collaboration(Organization) | domestic_partnership(Organization))",
      "(domestic_partnership(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(partnership_agreement(Organization, Partner) -> (domestic_partnership(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))))",
      "(scheduled_meeting(Organization, RegulatoryBody) -> regulatory_meeting(Organization, RegulatoryBody))",
      "(attends_meeting(Organization, RegulatoryBody) -> (scheduled_meeting(Organization, RegulatoryBody) -> regulatory_meeting(Organization, RegulatoryBody)))",
      "(fails_funding(Organization, Disease) -> -receives_funding(Organization, Disease))",
      "(completes_study(Organization, Animal) -> market_approval(Treatment))",
      "(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
      "(submits_data(Organization, RegulatoryBody) -> passes_review(RegulatoryBody, Organization))",
      "(-(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> requests_additional_data(RegulatoryBody, Organization))",
      "(-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> delays_study(Organization))",
      "(-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> -delays_study(Organization))",
      "(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> applies_authorization(Organization, Authorization))",
      "(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization))",
      "(-(initiates_trial(Organization, Treatment) -> (phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment))) -> abandons_trial(Organization, Treatment))",
      "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> regulatory_meeting(Organization, RegulatoryBody))",
      "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> scheduled_meeting(Organization, RegulatoryBody))",
      "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> -regulatory_meeting(Organization, RegulatoryBody))",
      "(-(-(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> requests_additional_data(RegulatoryBody, Organization)) -> denies_application(RegulatoryBody, Organization))",
      "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> receives_funding(Organization, Disease))",
      "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease))",
      "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> -receives_funding(Organization, Disease))",
      "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> restructures(Organization))",
      "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> -restructures(Organization))",
      "(-(-market_approval(Treatment) -> has_approval(Organization, Authorization)) -> conducts_research(Organization, Disease))",
      "(-attends_meeting(Organization, RegulatoryBody) -> misses_meeting(Organization, RegulatoryBody))",
      "(-market_approval(Treatment) -> has_approval(Organization, Authorization))",
      "(-market_approval(Treatment) -> -has_approval(Organization, Authorization))",
      "approves_application(RegulatoryBody, Organization)",
      "receives_clearance(Organization, Treatment)",
      "initiates_trial(Organization, Treatment)",
      "peer_review(Organization, Study)",
      "journal_submission(Organization, Study)",
      "data_analysis(Organization, Study)",
      "partnership_agreement(Organization, Partner)",
      "attends_meeting(Organization, RegulatoryBody)",
      "completes_study(Organization, Animal)",
      "submits_data(Organization, RegulatoryBody)",
      "market_approval(Treatment)",
      "-requests_additional_data(RegulatoryBody, Organization)",
      "-denies_application(RegulatoryBody, Organization)",
      "-violates_protocol(Organization)",
      "-appeals_decision(Organization)",
      "-conducts_research(Organization, Disease)",
      "-public_disclosure(Organization)",
      "-abandons_trial(Organization, Treatment)",
      "-develops_treatment(Organization, Disease)",
      "-misses_meeting(Organization, RegulatoryBody)"
    ],
    "natural_expressions": [
      "If a regulatory body passes an organization's review, then it follows that if the organization completes an animal study, then the treatment receives market approval.",
      "Provided that a regulatory body approves an organization's application, it is not the case that the regulatory body denies the organization's application.",
      "Whenever an organization uses a vehicle, the treatment obtains market approval.",
      "Either an organization uses a vehicle or the organization employs alternative transportation.",
      "Should an organization adopt alternative transportation, then the treatment is approved for the market.",
      "In the event that an organization violates a protocol, the organization faces penalties.",
      "If an organization violates a protocol, then the organization does not face penalties.",
      "An organization violates a protocol or, if it is not the case that using a vehicle implies market approval for the treatment, then the organization delays the study.",
      "Either an organization appeals a decision, or if it violates a protocol, then it does not face penalties.",
      "Under the condition that an organization conducts research on a disease, the organization develops a treatment for that disease.",
      "Whenever an organization hires a consultant, the organization appeals a decision.",
      "An organization hires a consultant or the organization conducts an internal review.",
      "If an organization performs an internal review, then should the organization violate a protocol, it will not face penalties.",
      "Either an organization makes a public disclosure, or the organization hires a consultant, or the organization conducts an internal review.",
      "Provided that an organization receives clearance for a treatment, the treatment receives market approval.",
      "Should an organization achieve phase 1 success for a treatment, then the organization receives clearance for that treatment.",
      "An organization attains phase 1 success for a treatment or the organization achieves phase 2 success for the treatment.",
      "In the event that an organization achieves phase 2 success for a treatment, the organization receives clearance for the treatment.",
      "If an organization initiates a trial for a treatment, then either the organization achieves phase 1 success or phase 2 success for the treatment.",
      "Whenever an organization's study undergoes peer review, then if the organization completes an animal study, the treatment receives market approval.",
      "Provided that an organization's study is peer-reviewed, the study is accepted for publication.",
      "If a study is accepted for publication, then under the condition that the organization completes an animal study, the treatment receives market approval.",
      "Should an organization submit a study to a journal, then if the study undergoes peer review, the study is accepted for publication.",
      "In the event that an organization performs data analysis on a study, the organization submits the study to a journal.",
      "If an organization engages in international collaboration, then provided that the organization completes an animal study, the treatment receives market approval.",
      "An organization pursues international collaboration or the organization enters a domestic partnership.",
      "Whenever an organization participates in a domestic partnership, then if the organization completes an animal study, the treatment obtains market approval.",
      "Under the condition that an organization enters a partnership agreement with a partner, then if the organization has a domestic partnership, then if the organization completes an animal study, the treatment receives market approval.",
      "If an organization schedules a meeting with a regulatory body, then a regulatory meeting between the organization and the regulatory body occurs.",
      "Provided that an organization attends a meeting with a regulatory body, then if the organization schedules a meeting, a regulatory meeting happens.",
      "Should an organization fail to obtain funding for a disease, then it is not the case that the organization receives funding for the disease.",
      "In the event that an organization completes an animal study, the treatment receives market approval.",
      "If an organization submits data to a regulatory body, then under the condition that the organization completes an animal study, the treatment receives market approval.",
      "Whenever an organization submits data to a regulatory body, the regulatory body passes the organization's review.",
      "If it is not the case that passing review implies that completing an animal study leads to market approval, then the regulatory body requests additional data from the organization.",
      "Should it not be the case that using a vehicle results in market approval for the treatment, then the organization delays the study.",
      "If it is not true that using a vehicle implies market approval for the treatment, then the organization does not delay the study.",
      "In the event that it is not the case that conducting research on a disease leads to developing a treatment, then the organization applies for authorization.",
      "Provided that it is not true that conducting research implies developing a treatment, then the organization does not apply for authorization.",
      "If it is not the case that initiating a trial results in phase 1 or phase 2 success, then the organization abandons the trial for the treatment.",
      "Should it not be true that submitting data leads to completing an animal study implying market approval, then a regulatory meeting occurs between the organization and the regulatory body.",
      "If it is not the case that submitting data results in an animal study completion implying market approval, then the organization schedules a meeting with the regulatory body.",
      "In the event that it is not true that submitting data implies that an animal study completion leads to market approval, then a regulatory meeting does not take place.",
      "If it is not the case that the negation of passing review implying animal study completion leads to market approval results in a request for additional data, then the regulatory body denies the organization's application.",
      "Under the condition that it is not true that not conducting research leading to treatment development implies not applying for authorization, then the organization receives funding for the disease.",
      "Should it not be the case that not conducting research implying treatment development leads to not applying for authorization, then the organization fails to obtain funding for the disease.",
      "If it is not true that not conducting research resulting in treatment development implies not applying for authorization, then it is not the case that the organization receives funding for the disease.",
      "In the event that it is not the case that not not conducting research implying treatment development leading to not applying for authorization results in failing funding, then the organization restructures.",
      "Provided that it is not true that not not conducting research resulting in treatment development implying not applying for authorization leads to failing funding, then the organization does not restructure.",
      "Should it not be the case that not market approval implies having authorization, then the organization conducts research on the disease.",
      "If an organization does not attend a meeting with a regulatory body, then the organization misses the meeting.",
      "In the event that a treatment does not receive market approval, the organization possesses authorization.",
      "Provided that a treatment does not obtain market approval, it is not the case that the organization has authorization.",
      "A regulatory body approves an organization's application.",
      "An organization receives clearance for a treatment.",
      "An organization initiates a clinical trial for a treatment.",
      "An organization's study undergoes peer review.",
      "An organization submits a study to a journal.",
      "An organization performs data analysis on a study.",
      "An organization enters a partnership agreement with a partner.",
      "An organization attends a meeting with a regulatory body.",
      "An organization completes a study involving animal subjects.",
      "An organization submits data to a regulatory body.",
      "A treatment receives market approval.",
      "It is not the case that a regulatory body requests additional data from an organization.",
      "A regulatory body does not deny an organization's application.",
      "An organization does not violate a protocol.",
      "An organization does not appeal a decision.",
      "An organization does not conduct research on a disease.",
      "An organization does not make a public disclosure.",
      "An organization does not abandon a clinical trial for a treatment.",
      "An organization does not develop a treatment for a disease.",
      "An organization does not miss a meeting with a regulatory body."
    ],
    "node_mappings": {
      "(A10 → (A8 → G))": {
        "formal": "(A10 → (A8 → G))",
        "prover9": "(A10 -> (A8 -> G))",
        "prover9_expression": "(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If a regulatory body passes an organization's review, then it follows that if the organization completes an animal study, then the treatment receives market approval."
      },
      "(A13 → ¬A12)": {
        "formal": "(A13 → ¬A12)",
        "prover9": "(A13 -> -A12)",
        "prover9_expression": "(approves_application(RegulatoryBody, Organization) -> -denies_application(RegulatoryBody, Organization))",
        "natural": "Provided that a regulatory body approves an organization's application, it is not the case that the regulatory body denies the organization's application."
      },
      "(A14 → G)": {
        "formal": "(A14 → G)",
        "prover9": "(A14 -> G)",
        "prover9_expression": "(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment))",
        "natural": "Whenever an organization uses a vehicle, the treatment obtains market approval."
      },
      "(A14 ∨ A15)": {
        "formal": "(A14 ∨ A15)",
        "prover9": "(A14 | A15)",
        "prover9_expression": "(uses_vehicle(Organization, Vehicle) | alternative_transport(Organization))",
        "natural": "Either an organization uses a vehicle or the organization employs alternative transportation."
      },
      "(A15 → G)": {
        "formal": "(A15 → G)",
        "prover9": "(A15 -> G)",
        "prover9_expression": "(alternative_transport(Organization) -> market_approval(Treatment))",
        "natural": "Should an organization adopt alternative transportation, then the treatment is approved for the market."
      },
      "(A17 → A18)": {
        "formal": "(A17 → A18)",
        "prover9": "(A17 -> A18)",
        "prover9_expression": "(violates_protocol(Organization) -> faces_penalties(Organization))",
        "natural": "In the event that an organization violates a protocol, the organization faces penalties."
      },
      "(A17 → ¬A18)": {
        "formal": "(A17 → ¬A18)",
        "prover9": "(A17 -> -A18)",
        "prover9_expression": "(violates_protocol(Organization) -> -faces_penalties(Organization))",
        "natural": "If an organization violates a protocol, then the organization does not face penalties."
      },
      "(A17 ∨ (¬(A14 → G) → A16))": {
        "formal": "(A17 ∨ (¬(A14 → G) → A16))",
        "prover9": "(A17 | (-(A14 -> G) -> A16))",
        "prover9_expression": "(violates_protocol(Organization) | (-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> delays_study(Organization)))",
        "natural": "An organization violates a protocol or, if it is not the case that using a vehicle implies market approval for the treatment, then the organization delays the study."
      },
      "(A19 ∨ (A17 → ¬A18))": {
        "formal": "(A19 ∨ (A17 → ¬A18))",
        "prover9": "(A19 | (A17 -> -A18))",
        "prover9_expression": "(appeals_decision(Organization) | (violates_protocol(Organization) -> -faces_penalties(Organization)))",
        "natural": "Either an organization appeals a decision, or if it violates a protocol, then it does not face penalties."
      },
      "(A2 → A3)": {
        "formal": "(A2 → A3)",
        "prover9": "(A2 -> A3)",
        "prover9_expression": "(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease))",
        "natural": "Under the condition that an organization conducts research on a disease, the organization develops a treatment for that disease."
      },
      "(A20 → A19)": {
        "formal": "(A20 → A19)",
        "prover9": "(A20 -> A19)",
        "prover9_expression": "(hires_consultant(Organization) -> appeals_decision(Organization))",
        "natural": "Whenever an organization hires a consultant, the organization appeals a decision."
      },
      "(A20 ∨ A21)": {
        "formal": "(A20 ∨ A21)",
        "prover9": "(A20 | A21)",
        "prover9_expression": "(hires_consultant(Organization) | internal_review(Organization))",
        "natural": "An organization hires a consultant or the organization conducts an internal review."
      },
      "(A21 → (A17 → ¬A18))": {
        "formal": "(A21 → (A17 → ¬A18))",
        "prover9": "(A21 -> (A17 -> -A18))",
        "prover9_expression": "(internal_review(Organization) -> (violates_protocol(Organization) -> -faces_penalties(Organization)))",
        "natural": "If an organization performs an internal review, then should the organization violate a protocol, it will not face penalties."
      },
      "(A22 ∨ (A20 ∨ A21))": {
        "formal": "(A22 ∨ (A20 ∨ A21))",
        "prover9": "(A22 | (A20 | A21))",
        "prover9_expression": "(public_disclosure(Organization) | (hires_consultant(Organization) | internal_review(Organization)))",
        "natural": "Either an organization makes a public disclosure, or the organization hires a consultant, or the organization conducts an internal review."
      },
      "(A23 → G)": {
        "formal": "(A23 → G)",
        "prover9": "(A23 -> G)",
        "prover9_expression": "(receives_clearance(Organization, Treatment) -> market_approval(Treatment))",
        "natural": "Provided that an organization receives clearance for a treatment, the treatment receives market approval."
      },
      "(A24 → A23)": {
        "formal": "(A24 → A23)",
        "prover9": "(A24 -> A23)",
        "prover9_expression": "(phase1_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
        "natural": "Should an organization achieve phase 1 success for a treatment, then the organization receives clearance for that treatment."
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment))",
        "natural": "An organization attains phase 1 success for a treatment or the organization achieves phase 2 success for the treatment."
      },
      "(A25 → A23)": {
        "formal": "(A25 → A23)",
        "prover9": "(A25 -> A23)",
        "prover9_expression": "(phase2_success(Organization, Treatment) -> receives_clearance(Organization, Treatment))",
        "natural": "In the event that an organization achieves phase 2 success for a treatment, the organization receives clearance for the treatment."
      },
      "(A26 → (A24 ∨ A25))": {
        "formal": "(A26 → (A24 ∨ A25))",
        "prover9": "(A26 -> (A24 | A25))",
        "prover9_expression": "(initiates_trial(Organization, Treatment) -> (phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment)))",
        "natural": "If an organization initiates a trial for a treatment, then either the organization achieves phase 1 success or phase 2 success for the treatment."
      },
      "(A28 → (A8 → G))": {
        "formal": "(A28 → (A8 → G))",
        "prover9": "(A28 -> (A8 -> G))",
        "prover9_expression": "(peer_review(Organization, Study) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "Whenever an organization's study undergoes peer review, then if the organization completes an animal study, the treatment receives market approval."
      },
      "(A28 → A29)": {
        "formal": "(A28 → A29)",
        "prover9": "(A28 -> A29)",
        "prover9_expression": "(peer_review(Organization, Study) -> publication_accepted(Study))",
        "natural": "Provided that an organization's study is peer-reviewed, the study is accepted for publication."
      },
      "(A29 → (A8 → G))": {
        "formal": "(A29 → (A8 → G))",
        "prover9": "(A29 -> (A8 -> G))",
        "prover9_expression": "(publication_accepted(Study) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If a study is accepted for publication, then under the condition that the organization completes an animal study, the treatment receives market approval."
      },
      "(A30 → (A28 → A29))": {
        "formal": "(A30 → (A28 → A29))",
        "prover9": "(A30 -> (A28 -> A29))",
        "prover9_expression": "(journal_submission(Organization, Study) -> (peer_review(Organization, Study) -> publication_accepted(Study)))",
        "natural": "Should an organization submit a study to a journal, then if the study undergoes peer review, the study is accepted for publication."
      },
      "(A31 → A30)": {
        "formal": "(A31 → A30)",
        "prover9": "(A31 -> A30)",
        "prover9_expression": "(data_analysis(Organization, Study) -> journal_submission(Organization, Study))",
        "natural": "In the event that an organization performs data analysis on a study, the organization submits the study to a journal."
      },
      "(A32 → (A8 → G))": {
        "formal": "(A32 → (A8 → G))",
        "prover9": "(A32 -> (A8 -> G))",
        "prover9_expression": "(international_collaboration(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If an organization engages in international collaboration, then provided that the organization completes an animal study, the treatment receives market approval."
      },
      "(A32 ∨ A33)": {
        "formal": "(A32 ∨ A33)",
        "prover9": "(A32 | A33)",
        "prover9_expression": "(international_collaboration(Organization) | domestic_partnership(Organization))",
        "natural": "An organization pursues international collaboration or the organization enters a domestic partnership."
      },
      "(A33 → (A8 → G))": {
        "formal": "(A33 → (A8 → G))",
        "prover9": "(A33 -> (A8 -> G))",
        "prover9_expression": "(domestic_partnership(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "Whenever an organization participates in a domestic partnership, then if the organization completes an animal study, the treatment obtains market approval."
      },
      "(A34 → (A33 → (A8 → G)))": {
        "formal": "(A34 → (A33 → (A8 → G)))",
        "prover9": "(A34 -> (A33 -> (A8 -> G)))",
        "prover9_expression": "(partnership_agreement(Organization, Partner) -> (domestic_partnership(Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))))",
        "natural": "Under the condition that an organization enters a partnership agreement with a partner, then if the organization has a domestic partnership, then if the organization completes an animal study, the treatment receives market approval."
      },
      "(A36 → A35)": {
        "formal": "(A36 → A35)",
        "prover9": "(A36 -> A35)",
        "prover9_expression": "(scheduled_meeting(Organization, RegulatoryBody) -> regulatory_meeting(Organization, RegulatoryBody))",
        "natural": "If an organization schedules a meeting with a regulatory body, then a regulatory meeting between the organization and the regulatory body occurs."
      },
      "(A37 → (A36 → A35))": {
        "formal": "(A37 → (A36 → A35))",
        "prover9": "(A37 -> (A36 -> A35))",
        "prover9_expression": "(attends_meeting(Organization, RegulatoryBody) -> (scheduled_meeting(Organization, RegulatoryBody) -> regulatory_meeting(Organization, RegulatoryBody)))",
        "natural": "Provided that an organization attends a meeting with a regulatory body, then if the organization schedules a meeting, a regulatory meeting happens."
      },
      "(A6 → ¬A5)": {
        "formal": "(A6 → ¬A5)",
        "prover9": "(A6 -> -A5)",
        "prover9_expression": "(fails_funding(Organization, Disease) -> -receives_funding(Organization, Disease))",
        "natural": "Should an organization fail to obtain funding for a disease, then it is not the case that the organization receives funding for the disease."
      },
      "(A8 → G)": {
        "formal": "(A8 → G)",
        "prover9": "(A8 -> G)",
        "prover9_expression": "(completes_study(Organization, Animal) -> market_approval(Treatment))",
        "natural": "In the event that an organization completes an animal study, the treatment receives market approval."
      },
      "(A9 → (A8 → G))": {
        "formal": "(A9 → (A8 → G))",
        "prover9": "(A9 -> (A8 -> G))",
        "prover9_expression": "(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment)))",
        "natural": "If an organization submits data to a regulatory body, then under the condition that the organization completes an animal study, the treatment receives market approval."
      },
      "(A9 → A10)": {
        "formal": "(A9 → A10)",
        "prover9": "(A9 -> A10)",
        "prover9_expression": "(submits_data(Organization, RegulatoryBody) -> passes_review(RegulatoryBody, Organization))",
        "natural": "Whenever an organization submits data to a regulatory body, the regulatory body passes the organization's review."
      },
      "(¬(A10 → (A8 → G)) → A11)": {
        "formal": "(¬(A10 → (A8 → G)) → A11)",
        "prover9": "(-(A10 -> (A8 -> G)) -> A11)",
        "prover9_expression": "(-(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> requests_additional_data(RegulatoryBody, Organization))",
        "natural": "If it is not the case that passing review implies that completing an animal study leads to market approval, then the regulatory body requests additional data from the organization."
      },
      "(¬(A14 → G) → A16)": {
        "formal": "(¬(A14 → G) → A16)",
        "prover9": "(-(A14 -> G) -> A16)",
        "prover9_expression": "(-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> delays_study(Organization))",
        "natural": "Should it not be the case that using a vehicle results in market approval for the treatment, then the organization delays the study."
      },
      "(¬(A14 → G) → ¬A16)": {
        "formal": "(¬(A14 → G) → ¬A16)",
        "prover9": "(-(A14 -> G) -> -A16)",
        "prover9_expression": "(-(uses_vehicle(Organization, Vehicle) -> market_approval(Treatment)) -> -delays_study(Organization))",
        "natural": "If it is not true that using a vehicle implies market approval for the treatment, then the organization does not delay the study."
      },
      "(¬(A2 → A3) → A4)": {
        "formal": "(¬(A2 → A3) → A4)",
        "prover9": "(-(A2 -> A3) -> A4)",
        "prover9_expression": "(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> applies_authorization(Organization, Authorization))",
        "natural": "In the event that it is not the case that conducting research on a disease leads to developing a treatment, then the organization applies for authorization."
      },
      "(¬(A2 → A3) → ¬A4)": {
        "formal": "(¬(A2 → A3) → ¬A4)",
        "prover9": "(-(A2 -> A3) -> -A4)",
        "prover9_expression": "(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization))",
        "natural": "Provided that it is not true that conducting research implies developing a treatment, then the organization does not apply for authorization."
      },
      "(¬(A26 → (A24 ∨ A25)) → A27)": {
        "formal": "(¬(A26 → (A24 ∨ A25)) → A27)",
        "prover9": "(-(A26 -> (A24 | A25)) -> A27)",
        "prover9_expression": "(-(initiates_trial(Organization, Treatment) -> (phase1_success(Organization, Treatment) | phase2_success(Organization, Treatment))) -> abandons_trial(Organization, Treatment))",
        "natural": "If it is not the case that initiating a trial results in phase 1 or phase 2 success, then the organization abandons the trial for the treatment."
      },
      "(¬(A9 → (A8 → G)) → A35)": {
        "formal": "(¬(A9 → (A8 → G)) → A35)",
        "prover9": "(-(A9 -> (A8 -> G)) -> A35)",
        "prover9_expression": "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> regulatory_meeting(Organization, RegulatoryBody))",
        "natural": "Should it not be true that submitting data leads to completing an animal study implying market approval, then a regulatory meeting occurs between the organization and the regulatory body."
      },
      "(¬(A9 → (A8 → G)) → A36)": {
        "formal": "(¬(A9 → (A8 → G)) → A36)",
        "prover9": "(-(A9 -> (A8 -> G)) -> A36)",
        "prover9_expression": "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> scheduled_meeting(Organization, RegulatoryBody))",
        "natural": "If it is not the case that submitting data results in an animal study completion implying market approval, then the organization schedules a meeting with the regulatory body."
      },
      "(¬(A9 → (A8 → G)) → ¬A35)": {
        "formal": "(¬(A9 → (A8 → G)) → ¬A35)",
        "prover9": "(-(A9 -> (A8 -> G)) -> -A35)",
        "prover9_expression": "(-(submits_data(Organization, RegulatoryBody) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> -regulatory_meeting(Organization, RegulatoryBody))",
        "natural": "In the event that it is not true that submitting data implies that an animal study completion leads to market approval, then a regulatory meeting does not take place."
      },
      "(¬(¬(A10 → (A8 → G)) → A11) → A12)": {
        "formal": "(¬(¬(A10 → (A8 → G)) → A11) → A12)",
        "prover9": "(-(-(A10 -> (A8 -> G)) -> A11) -> A12)",
        "prover9_expression": "(-(-(passes_review(RegulatoryBody, Organization) -> (completes_study(Organization, Animal) -> market_approval(Treatment))) -> requests_additional_data(RegulatoryBody, Organization)) -> denies_application(RegulatoryBody, Organization))",
        "natural": "If it is not the case that the negation of passing review implying animal study completion leads to market approval results in a request for additional data, then the regulatory body denies the organization's application."
      },
      "(¬(¬(A2 → A3) → ¬A4) → A5)": {
        "formal": "(¬(¬(A2 → A3) → ¬A4) → A5)",
        "prover9": "(-(-(A2 -> A3) -> -A4) -> A5)",
        "prover9_expression": "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> receives_funding(Organization, Disease))",
        "natural": "Under the condition that it is not true that not conducting research leading to treatment development implies not applying for authorization, then the organization receives funding for the disease."
      },
      "(¬(¬(A2 → A3) → ¬A4) → A6)": {
        "formal": "(¬(¬(A2 → A3) → ¬A4) → A6)",
        "prover9": "(-(-(A2 -> A3) -> -A4) -> A6)",
        "prover9_expression": "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease))",
        "natural": "Should it not be the case that not conducting research implying treatment development leads to not applying for authorization, then the organization fails to obtain funding for the disease."
      },
      "(¬(¬(A2 → A3) → ¬A4) → ¬A5)": {
        "formal": "(¬(¬(A2 → A3) → ¬A4) → ¬A5)",
        "prover9": "(-(-(A2 -> A3) -> -A4) -> -A5)",
        "prover9_expression": "(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> -receives_funding(Organization, Disease))",
        "natural": "If it is not true that not conducting research resulting in treatment development implies not applying for authorization, then it is not the case that the organization receives funding for the disease."
      },
      "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → A7)": {
        "formal": "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → A7)",
        "prover9": "(-(-(-(A2 -> A3) -> -A4) -> A6) -> A7)",
        "prover9_expression": "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> restructures(Organization))",
        "natural": "In the event that it is not the case that not not conducting research implying treatment development leading to not applying for authorization results in failing funding, then the organization restructures."
      },
      "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → ¬A7)": {
        "formal": "(¬(¬(¬(A2 → A3) → ¬A4) → A6) → ¬A7)",
        "prover9": "(-(-(-(A2 -> A3) -> -A4) -> A6) -> -A7)",
        "prover9_expression": "(-(-(-(conducts_research(Organization, Disease) -> develops_treatment(Organization, Disease)) -> -applies_authorization(Organization, Authorization)) -> fails_funding(Organization, Disease)) -> -restructures(Organization))",
        "natural": "Provided that it is not true that not not conducting research resulting in treatment development implying not applying for authorization leads to failing funding, then the organization does not restructure."
      },
      "(¬(¬G → A1) → A2)": {
        "formal": "(¬(¬G → A1) → A2)",
        "prover9": "(-(-G -> A1) -> A2)",
        "prover9_expression": "(-(-market_approval(Treatment) -> has_approval(Organization, Authorization)) -> conducts_research(Organization, Disease))",
        "natural": "Should it not be the case that not market approval implies having authorization, then the organization conducts research on the disease."
      },
      "(¬A37 → A38)": {
        "formal": "(¬A37 → A38)",
        "prover9": "(-A37 -> A38)",
        "prover9_expression": "(-attends_meeting(Organization, RegulatoryBody) -> misses_meeting(Organization, RegulatoryBody))",
        "natural": "If an organization does not attend a meeting with a regulatory body, then the organization misses the meeting."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-market_approval(Treatment) -> has_approval(Organization, Authorization))",
        "natural": "In the event that a treatment does not receive market approval, the organization possesses authorization."
      },
      "(¬G → ¬A1)": {
        "formal": "(¬G → ¬A1)",
        "prover9": "(-G -> -A1)",
        "prover9_expression": "(-market_approval(Treatment) -> -has_approval(Organization, Authorization))",
        "natural": "Provided that a treatment does not obtain market approval, it is not the case that the organization has authorization."
      },
      "A13": {
        "formal": "A13",
        "prover9": "A13",
        "prover9_expression": "approves_application(RegulatoryBody, Organization)",
        "natural": "A regulatory body approves an organization's application."
      },
      "A23": {
        "formal": "A23",
        "prover9": "A23",
        "prover9_expression": "receives_clearance(Organization, Treatment)",
        "natural": "An organization receives clearance for a treatment."
      },
      "A26": {
        "formal": "A26",
        "prover9": "A26",
        "prover9_expression": "initiates_trial(Organization, Treatment)",
        "natural": "An organization initiates a clinical trial for a treatment."
      },
      "A28": {
        "formal": "A28",
        "prover9": "A28",
        "prover9_expression": "peer_review(Organization, Study)",
        "natural": "An organization's study undergoes peer review."
      },
      "A30": {
        "formal": "A30",
        "prover9": "A30",
        "prover9_expression": "journal_submission(Organization, Study)",
        "natural": "An organization submits a study to a journal."
      },
      "A31": {
        "formal": "A31",
        "prover9": "A31",
        "prover9_expression": "data_analysis(Organization, Study)",
        "natural": "An organization performs data analysis on a study."
      },
      "A34": {
        "formal": "A34",
        "prover9": "A34",
        "prover9_expression": "partnership_agreement(Organization, Partner)",
        "natural": "An organization enters a partnership agreement with a partner."
      },
      "A37": {
        "formal": "A37",
        "prover9": "A37",
        "prover9_expression": "attends_meeting(Organization, RegulatoryBody)",
        "natural": "An organization attends a meeting with a regulatory body."
      },
      "A8": {
        "formal": "A8",
        "prover9": "A8",
        "prover9_expression": "completes_study(Organization, Animal)",
        "natural": "An organization completes a study involving animal subjects."
      },
      "A9": {
        "formal": "A9",
        "prover9": "A9",
        "prover9_expression": "submits_data(Organization, RegulatoryBody)",
        "natural": "An organization submits data to a regulatory body."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "market_approval(Treatment)",
        "natural": "A treatment receives market approval."
      },
      "¬A11": {
        "formal": "¬A11",
        "prover9": "-A11",
        "prover9_expression": "-requests_additional_data(RegulatoryBody, Organization)",
        "natural": "It is not the case that a regulatory body requests additional data from an organization."
      },
      "¬A12": {
        "formal": "¬A12",
        "prover9": "-A12",
        "prover9_expression": "-denies_application(RegulatoryBody, Organization)",
        "natural": "A regulatory body does not deny an organization's application."
      },
      "¬A17": {
        "formal": "¬A17",
        "prover9": "-A17",
        "prover9_expression": "-violates_protocol(Organization)",
        "natural": "An organization does not violate a protocol."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-appeals_decision(Organization)",
        "natural": "An organization does not appeal a decision."
      },
      "¬A2": {
        "formal": "¬A2",
        "prover9": "-A2",
        "prover9_expression": "-conducts_research(Organization, Disease)",
        "natural": "An organization does not conduct research on a disease."
      },
      "¬A22": {
        "formal": "¬A22",
        "prover9": "-A22",
        "prover9_expression": "-public_disclosure(Organization)",
        "natural": "An organization does not make a public disclosure."
      },
      "¬A27": {
        "formal": "¬A27",
        "prover9": "-A27",
        "prover9_expression": "-abandons_trial(Organization, Treatment)",
        "natural": "An organization does not abandon a clinical trial for a treatment."
      },
      "¬A3": {
        "formal": "¬A3",
        "prover9": "-A3",
        "prover9_expression": "-develops_treatment(Organization, Disease)",
        "natural": "An organization does not develop a treatment for a disease."
      },
      "¬A38": {
        "formal": "¬A38",
        "prover9": "-A38",
        "prover9_expression": "-misses_meeting(Organization, RegulatoryBody)",
        "natural": "An organization does not miss a meeting with a regulatory body."
      }
    }
  }
}